Melanoma Research Alliance: 2022-2023 RFP

MRA 2022-2023 Request for Proposals - Now Open

The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment.

Proposals will be accepted for Established Investigator Awards, Academic-Industry Partnership Awards, Young Investigator Awards, and Pilot Awards.  We intend to support at least $11.5 million in new funding through this RFP.

Special Opportunities Included in RFP:

• Immunotherapy Young Investigator Awards supported by Bristol Myers Squibb (BMS)
• Radiation Oncology Young Investigator Award co-funded with the American Society for Radiation Oncology (ASTRO)
• Metastatic Uveal Melanoma Pilot Award co-funded with A Cure in Sight
• Patient-Centric Clinical Trials Team Science Awards co-funded with the Rising Tide Foundation for Clinical Cancer Research (RTFCCR) 

Please Note the Following Key Deadlines:

• October 5: Letters of Intent Due for RTFCCR-MRA Team Science Awards on Patient-Centered Clinical Trials
• October 19: Young Investigator Award Eligibility Checklist Due
• November 2: Full Proposals Due

All proposals are due by 11:59 pm Eastern Time. Proposals should be submitted via the proposalCENTRAL on-line application tool: https://proposalcentral.com/.